Dietary Treatment of Glucose Transporter Type 1 Deficiency (G1D)

Trial Profile

Dietary Treatment of Glucose Transporter Type 1 Deficiency (G1D)

Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 25 Oct 2017

At a glance

  • Drugs Triheptanoin (Primary)
  • Indications De Vivo disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 17 Oct 2017 Planned End Date changed from 30 Jun 2022 to 30 Nov 2022.
    • 17 Oct 2017 Planned primary completion date changed from 30 Jun 2019 to 30 Nov 2019.
    • 17 Oct 2017 Planned initiation date changed from 30 Jun 2017 to 30 Nov 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top